203 related articles for article (PubMed ID: 4829021)
1. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
Sala Felis T; Berenguer J; Barrios JM; Gómez J
Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
[No Abstract] [Full Text] [Related]
2. Portal systemic encephalopathy--should lactulose and neomycin be used together.
Martin AJ
Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
[No Abstract] [Full Text] [Related]
3. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
[TBL] [Abstract][Full Text] [Related]
4. Lactulose for hepatic encephalopathy.
Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
[No Abstract] [Full Text] [Related]
5. [Lactulose in the treatment of hepatic (pre)coma].
Grijm R
Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
[No Abstract] [Full Text] [Related]
6. Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?
Capocaccia L; Riggio O
Hepatology; 1990 Aug; 12(2):368-70. PubMed ID: 2391075
[No Abstract] [Full Text] [Related]
7. [Lactulose in the therapy of porto-systemic encephalopathy].
Almici C; Inzoli MR; Poloni AE; Zambruni A
Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
[No Abstract] [Full Text] [Related]
8. Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.
Orlandi F; Freddara U; Candelaresi MT; Morettini A; Corazza GR; Di Simone A; Dobrilla G; Cavallini G
Dig Dis Sci; 1981 Jun; 26(6):498-506. PubMed ID: 7016484
[TBL] [Abstract][Full Text] [Related]
9. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
Atterbury CE; Maddrey WC; Conn HO
Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
[TBL] [Abstract][Full Text] [Related]
10. Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode.
Mann NS; Borkar BB; Narenderan KP; Kadian RS; Mann SK; Martin RL
Am J Gastroenterol; 1979 Aug; 72(2):141-5. PubMed ID: 38663
[TBL] [Abstract][Full Text] [Related]
11. The use of lactulose in portal-systemic encephalopathy.
Matthews SJ
Conn Med; 1978 Feb; 42(2):96-7. PubMed ID: 630868
[No Abstract] [Full Text] [Related]
12. [Treatment of hepatic encephalopathy with lactulose].
Veljkov N; Kulenović S; Borovac N; Rezaković D
Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
[No Abstract] [Full Text] [Related]
13. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Pirotte J; Guffens JM; Devos J
Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
[No Abstract] [Full Text] [Related]
14. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
Leonhardt H; Sanhueza P
Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
[No Abstract] [Full Text] [Related]
15. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
Elkington SG; Floch MH; Conn HO
N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
[No Abstract] [Full Text] [Related]
16. Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol.
Rodgers JB; Kiley JE; Balint JA
Am J Gastroenterol; 1973 Nov; 60(5):459-65. PubMed ID: 4587191
[No Abstract] [Full Text] [Related]
17. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
[No Abstract] [Full Text] [Related]
18. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
[TBL] [Abstract][Full Text] [Related]
19. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
[No Abstract] [Full Text] [Related]
20. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
Bircher J; Gmünder U; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
Strahlentherapie Sonderb; 1968; 67():330-6. PubMed ID: 5719130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
